Hyperthermic intraperitoneal chemotherapy is associated with improved overall survival in advanced non–high-grade epithelial ovarian, fallopian tube, and primary peritoneal carcinoma
Elsevier ·
The publisher did not provide an abstract — full text is available via the link below.
Hyperthermic intraperitoneal chemotherapy is associated with improved overall survival in advanced non–high-grade epithelial ovarian, fallopian tube, and primary peritoneal carcinoma. // International Journal of Gynecological Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1048891X26005347?dgcid=rss_sd_all
Hyperthermic intraperitoneal chemotherapy is associated with improved overall survival in advanced non–high-grade epithelial ovarian, fallopian tube, and primary peritoneal carcinoma. International Journal of Gynecological Cancer. https://www.sciencedirect.com/science/article/pii/S1048891X26005347?dgcid=rss_sd_all
“Hyperthermic intraperitoneal chemotherapy is associated with improved overall survival in advanced non–high-grade epithelial ovarian, fallopian tube, and primary peritoneal carcinoma.” International Journal of Gynecological Cancer.
@article{article89514,
title = {Hyperthermic intraperitoneal chemotherapy is associated with improved overall survival in advanced non–high-grade epithelial ovarian, fallopian tube, and primary peritoneal carcinoma},
journal = {International Journal of Gynecological Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1048891X26005347?dgcid=rss_sd_all}
}